CD79A and amyotrophic lateral sclerosis: ECL analysis of ALS specimens showed that ETVAX alone or with dmLT adjuvant elicited significant increases of specific IgA antibody responses against all four vaccine CFs and LTB (Fig. 3 and Table 3).